Dr Ram Shankar UpadhayayaPolycystic Ovary Syndrome (PCOS) is commonly described as a reproductive disorder. For many women, it first appears as irregular menstrual cycles, acne, weight gain, or difficulty conceiving. Yet this traditional framing captures only part of a larger biological reality.Increasingly, PCOS is being recognized as one of the most prevalent metabolic disorders affecting women of reproductive age. In India, current estimates suggest that nearly one in five urban Indian women may exhibit features consistent with PCOS. Despite its prevalence, PCOS remains widely misunderstood-often treated symptom rather than addressed as a systemic condition with lifelong implications.Clinical diagnosis of PCOS relies on features such as irregular ovulation, hyperandrogenism, and polycystic ovarian morphology. However, reproductive symptoms represent only the visible surface of the disorder.A significant proportion of women with PCOS demonstrate insulin resistance; dyslipidemia (abnormal level of cholesterol and/or triglycerides); chronic low-grade inflammation; increased long-term risk of type 2 diabetes and cardiovascular disease; metabolic abnormalities precede fertility concerns and endocrine imbalance. The role of mitochondria — the cellular organelles responsible for energy production — in the biology of PCOS too needs consideration. Mitochondria regulate ATP generation, fatty-acid metabolism, oxidative balance, and key steps in steroid hormone synthesis. Ovarian granulosa cells and developing oocytes are highly energy-dependent, requiring efficient mitochondrial function for follicular maturation and ovulation. Several studies have reported altered mitochondrial activity, impaired oxidative metabolism, and increased oxidative stress markers in women with PCOS.Insulin resistance represents a central feature of PCOS. When tissues respond poorly to insulin, compensatory hyperinsulinemia develops. Elevated insulin levels directly stimulate ovarian androgen production and reduce circulating sex hormone–binding globulin, amplifying hormonal imbalance. From this perspective, hyperandrogenism may not occur in isolation but as part of a broader metabolic disturbance. Impaired cellular energy utilization and metabolic stress may therefore act upstream of the hormonal changes observed clinically.Mitochondrial inefficiency can increase production of reactive oxygen species, contributing to oxidative stress — a finding consistently reported in PCOS studies. Within the ovary, oxidative imbalance may disrupt granulosa cell signaling and follicular development. Multiple follicles initiate growth but fail to reach full maturation, resulting in the characteristic polycystic ovarian appearance and an ovulation.Oocyte competence depends heavily on mitochondrial integrity and adequate ATP availability. Research has identified altered mitochondrial structure and reduced mitochondrial DNA copy number in oocytes from some women with PCOS. These bioenergetic changes may partly explain variability in fertility outcomes and responses to assisted reproductive treatments, reinforcing that reproductive dysfunction in PCOS extends beyond hormonal regulation alone.Management of PCOS today focuses on symptom control and reduction of metabolic risk, tailored to patient priorities.Lifestyle modification remains first-line therapy. Weight management, structured exercise, and dietary interventions improve insulin sensitivity and can restore ovulation in some patients. Exercise is particularly beneficial because it enhances metabolic efficiency and mitochondrial function.Hormonal therapies, combined oral contraceptives, are widely used to regulate menstrual cycles and manage androgen-related symptoms. Insulin sensitizers, most commonly metformin, are prescribed to improve metabolic parameters and may support ovulatory function.Ovulation induction therapies, including letrozole and clomiphene citrate, are used when pregnancy is desired.Long-term monitoring for diabetes, lipid abnormalities, and cardiovascular risk is increasingly recommended.Future care for PCOS will likely move toward integrated, personalized approaches combining reproductive endocrinology with metabolic medicine. Advances in understanding cellular metabolism, oxidative stress, and energy regulation may open new avenues for prevention and treatment. PCOS should no longer be viewed solely as a reproductive concern. It may represent one of the earliest clinical signals of metabolic stress in young women-and therefore a critical opportunity for early intervention.(The writer is a US-based medical scientist)
